[HTML][HTML] Immune cell modulation of the extracellular matrix contributes to the pathogenesis of pancreatic cancer

RS Ahmad, TD Eubank, S Lukomski, BA Boone - Biomolecules, 2021 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a five-year
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …

[PDF][PDF] Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer. Biomolecules 2021, 11, 901

RS Ahmad, TD Eubank, S Lukomski, BA Boone - 2021 - pdfs.semanticscholar.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a fiveyear
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …

Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer

RS Ahmad, TD Eubank, S Lukomski… - Biomolecules, 2021 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a five-year
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …

Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer

RS Ahmad, TD Eubank, S Lukomski, BA Boone - 2021 - agris.fao.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a five-year
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …

Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.

RS Ahmad, TD Eubank, S Lukomski, BA Boone - Biomolecules, 2021 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a five-year
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …

[HTML][HTML] Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer

RS Ahmad, TD Eubank, S Lukomski, BA Boone - Biomolecules, 2021 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a five-year
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …

Immune cell modulation of the extracellular matrix contributes to the pathogenesis of pancreatic cancer

RS Ahmad, TD Eubank, S Lukomski… - …, 2021 - ohiostate.elsevierpure.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a fiveyear
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …

Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer

RS Ahmad, TD Eubank, S Lukomski… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a five-year
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …

Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.

RS Ahmad, TD Eubank, S Lukomski… - Biomolecules (2218 …, 2021 - search.ebscohost.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a five-year
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …